1. Home
  2. BDTX vs SOPH Comparison

BDTX vs SOPH Comparison

Compare BDTX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • SOPH
  • Stock Information
  • Founded
  • BDTX 2014
  • SOPH 2011
  • Country
  • BDTX United States
  • SOPH Switzerland
  • Employees
  • BDTX N/A
  • SOPH N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BDTX Health Care
  • SOPH Health Care
  • Exchange
  • BDTX Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • BDTX 292.0M
  • SOPH 309.2M
  • IPO Year
  • BDTX 2020
  • SOPH 2021
  • Fundamental
  • Price
  • BDTX $5.65
  • SOPH $4.66
  • Analyst Decision
  • BDTX Strong Buy
  • SOPH Strong Buy
  • Analyst Count
  • BDTX 3
  • SOPH 3
  • Target Price
  • BDTX $13.00
  • SOPH $7.33
  • AVG Volume (30 Days)
  • BDTX 864.0K
  • SOPH 92.6K
  • Earning Date
  • BDTX 08-09-2024
  • SOPH 08-06-2024
  • Dividend Yield
  • BDTX N/A
  • SOPH N/A
  • EPS Growth
  • BDTX N/A
  • SOPH N/A
  • EPS
  • BDTX N/A
  • SOPH N/A
  • Revenue
  • BDTX N/A
  • SOPH $64,184,000.00
  • Revenue This Year
  • BDTX N/A
  • SOPH $28.97
  • Revenue Next Year
  • BDTX N/A
  • SOPH $28.39
  • P/E Ratio
  • BDTX N/A
  • SOPH N/A
  • Revenue Growth
  • BDTX N/A
  • SOPH 26.68
  • 52 Week Low
  • BDTX $1.62
  • SOPH $2.13
  • 52 Week High
  • BDTX $7.66
  • SOPH $7.37
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 61.49
  • SOPH 48.26
  • Support Level
  • BDTX $4.28
  • SOPH $4.50
  • Resistance Level
  • BDTX $4.75
  • SOPH $4.66
  • Average True Range (ATR)
  • BDTX 0.38
  • SOPH 0.21
  • MACD
  • BDTX 0.11
  • SOPH 0.01
  • Stochastic Oscillator
  • BDTX 93.17
  • SOPH 66.00

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: